Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Daniel Busby's Stock Ratings
RBC Capital Analyst
Daniel Busby is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/27/2025
Overall Average Return
-8.02%
Smart Score
Overall Average Return Percentile
25th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/25/2022 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.46 | 760.77% | Daniel Busby35% | $16 → $4 | Downgrade | Outperform → Sector Perform | Get Alert |
| 08/09/2021 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | $6 → $5 | Maintains | Sector Perform | Get Alert |
| 07/27/2021 | AGRX | Buy Now | Agile Therapeutics | $1.51 | 231.13% | Daniel Busby35% | $12000 → $10000 | Maintains | Outperform | Get Alert |
| 06/17/2021 | PFE | Buy Now | Pfizer | $22.98 | 91.48% | Daniel Busby35% | $43 → $44 | Maintains | Sector Perform | Get Alert |
| 05/14/2021 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.46 | 3988.66% | Daniel Busby35% | → $19 | Initiates | → Outperform | Get Alert |
| 05/14/2021 | MNKD | Buy Now | MannKind | $4.60 | 8.7% | Daniel Busby35% | → $5 | Initiates | → Sector Perform | Get Alert |
| 05/03/2021 | ABBV | Buy Now | AbbVie | $185.94 | -27.4% | Daniel Busby35% | → $135 | Reiterates | → Outperform | Get Alert |
| 07/11/2019 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | $11 → $6 | Downgrade | Outperform → Sector Perform | Get Alert |
| 08/13/2018 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | — | Upgrade | Sector Perform → Outperform | Get Alert |
| 05/06/2016 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | — | Downgrade | Outperform → Sector Perform | Get Alert |
| 03/18/2016 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | $73 → $47 | Downgrade | Top Pick → Outperform | Get Alert |
| 11/04/2015 | MNKD | Buy Now | MannKind | $4.60 | -78.26% | Daniel Busby35% | $45 → $5 | Downgrade | Outperform → Underperform | Get Alert |
| 07/17/2015 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | $98 → $107 | Upgrade | Outperform → Top Pick | Get Alert |
| 09/02/2014 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | → $80 | Initiates | → Outperform | Get Alert |
| 02/07/2013 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | $25 → $24 | Downgrade | Sector Perform → Underperform | Get Alert |
| 10/05/2012 | ENDP | Buy Now | Endo International | — | — | Daniel Busby35% | — | Downgrade | Outperform → Sector Perform | Get Alert |
